| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.2 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.2 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |